Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

PRO.MED.CS Praha

PRO.MED.CS Praha a.s. is a Czech pharmaceutical Company located in Prague specialising in the manufacture of solid medicinal forms – tablets, film coated tablets and capsules. Our medicinal portfolio is primarily aimed at the cardiovascular, gastrointestinal and musculoskeletal areas and pain. We also provide medicines for mental disorders, bacterial and viral diseases. In addition to prescription medicines we produce over the counter medicines and trace elements too.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

PRO.MED.CS Praha
Telcska 1, Prague, 140 00, Czech Republic
+420 241 013 111
Contact PRO.MED.CS Praha
Website

 Latest Content from PMHub 

Accelerating Revenue Cycle Performance in the Healthcare Industry

Videos and Podcasts | November 11, 2021 | Impetus Digital

Michael Duke, Principal Healthcare Consultant at Baker Tilly US, discusses the importance of data and analytics for internal audits, organizational risk reduction, workflow automation, and to drive value in healthcare....

How femtech is changing the future of women’s health

Press Releases | November 11, 2021 | Thrive Agency

The femtech industry has the potential to be the next stage of evolution in the open access movement. Taking on the role of a public library, which allows a wider...

Revolutionising the Digital Content Delivery Model

White Papers and Resources | November 11, 2021 | M3 (EU)

Pharmaceutical industry processes don’t have to make the delivery of marketing campaigns slow and unmanageable, and thus ineffective. Changing working practices and really, truly thinking differently about how to deliver...

Fishawack Health welcomes expert-led dermatology initiative FIDE to its group

Press Releases | November 10, 2021 | Avalere Health

Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology

Opening up about patient engagement

White Papers and Resources | November 9, 2021 | Cuttsy + Cuttsy

Read the third blog of the series looking at key barriers to effective patient engagement in pharma

Rethinking immunodermatology: Patient and market insights from leading KOLs and life science leaders

White Papers and Resources | November 8, 2021 | Avalere Health

In our new publication, we speak to key opinion leaders and industry experts to uncover novel strategies for commercializing immunodermatology therapies in a crowded market landscape.

Delivering outcomes-led solutions with connected capabilities

Press Releases | November 8, 2021 | Lucid Group Communications Limited

Founded in 2007, Lucid Group has grown from a small UK-based medical education agency to a global healthcare consultancy and employs over 400 people with several offices in the UK...

Making Actionable Health Information More Accessible Through Point-of-Care Testing

Videos and Podcasts | November 4, 2021 | Impetus Digital

Hector Bremner, CEO of Avricore Health, discusses the benefits of comprehensive point-of-care testing for patient monitoring, real-world studies, and decentralized clinical trials; how his company is working on becoming the...

Pioneers of the First Virtual Hospital

Videos and Podcasts | November 4, 2021 | Impetus Digital

Raphael Rakowski, Executive Chairman of Medically Home, explores the concepts of “virtual hospitals” and “hospital-at-home,” including current barriers, benefits, and the many considerations for making it a reality.

Data-driven healthcare communications

Press Releases | November 3, 2021 | Lucid Group Communications Limited

Data analysis is everywhere, and the role it plays in our lives is increasing exponentially. From deciding what car to purchase to what medicine will be prescribed for us, the...